A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency

Institute for Asthma and Allergy, Chevy Chase

Allergy Associates of the Palm Beaches PA, North Palm Beach

Alabama Allergy & Asthma Center, Birmingham

Optimed Research, LLC, Columbus

The South Bend Clinic Center for Research, South Bend

Washington University, St Louis

Allergy, Asthma and Immunology Center, P.C., Tulsa

Allergy, Asthma & Immunology Clinic, P.A., Irving

Allergy Partners of North Texas Research, Dallas

AARA Research Center, Dallas